Chun‐Ping Cui
- Cancer Research top 5%
- Cancer, Hypoxia, and Metabolism 8
- Molecular Biology top 10%
- Ubiquitin and proteasome pathways 25
- RNA modifications and cancer 6
- Gut microbiota and health 5
- Biological Psychiatry top 10%
- Oncology top 10%
-
- Endoplasmic Reticulum Stress and Disease 8
-
- Multiple Sclerosis Research Studies 7
-
- Liver physiology and pathology 5
-
- Liver Disease Diagnosis and Treatment 5
- Journals
- Nature Communications (5 papers)Frontiers in Immunology (4 papers)Cell Death and Disease (3 papers)
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Chun‐Ping Cui
56 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 99
- Cancer Research 426
- Molecular Biology 1.2k
- Biological Psychiatry 37
- Oncology 338
- Immunology 209
Countries citing papers authored by Chun‐Ping Cui
This map shows the geographic impact of Chun‐Ping Cui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chun‐Ping Cui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chun‐Ping Cui more than expected).
Fields of papers citing papers by Chun‐Ping Cui
This network shows the impact of papers produced by Chun‐Ping Cui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chun‐Ping Cui. The network helps show where Chun‐Ping Cui may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Chun‐Ping Cui, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 5 | |
| 3 | 2024 | 0 | |
| 4 | 2024 | 2 | |
| 5 | 2024 | 3 | |
| 6 | 2023 | 12 | |
| 7 | 2023 | 7 | |
| 8 | 2022 | 30 | |
| 9 | 2022 | 16 | |
| 10 | 2022 | 14 | |
| 11 | 2022 | 24 | |
| 12 | 2021 | 80 | |
| 13 | 2021 | 9 | |
| 14 | 2021 | 5 | |
| 15 | 2021 | 8 | |
| 16 | 2020 | 7 | |
| 17 | 2019 | 7 | |
| 18 | 2019 | 56 | |
| 19 | 2010 | 3 | |
| 20 | 2008 | 14 |
About Chun‐Ping Cui
Chun‐Ping Cui is a scholar working on Cancer Research, Hepatology and Molecular Biology, having authored 61 papers that have together received 1.7k indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (25 papers), Cancer, Hypoxia, and Metabolism (8 papers), Endoplasmic Reticulum Stress and Disease (8 papers), Multiple Sclerosis Research Studies (7 papers), RNA modifications and cancer (6 papers), Liver physiology and pathology (5 papers), Gut microbiota and health (5 papers) and Liver Disease Diagnosis and Treatment (5 papers). The work is most often cited by research in Cancer Research (426 citations), Molecular Biology (1.2k citations) and Biological Psychiatry (37 citations). Chun‐Ping Cui has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Lingqiang Zhang, Wei Qiu, Cui Hua Liu, Fuchu He, Lin Fu, Hongchang Li, Zhiqiang Peng, Yifan Zhou, Xueli Zhang and Song Guo Zheng. Their work appears in journals such as Nature Communications, Frontiers in Immunology, Cell Death and Disease, Multiple Sclerosis and Related Disorders and Cell Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.